Skip to content

ATOSSA THERAPEUTICS, INC.: filings

Every ATOSSA THERAPEUTICS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 61 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-07fiscal Q2 202632950001193125-26-339257
10-Q2026-05-08fiscal Q1 202632670001193125-26-213423
10-K2026-03-25fiscal FY 202533670001193125-26-124396
10-Q2025-11-12fiscal Q3 202532990001193125-25-276160
10-Q2025-08-12fiscal Q2 202532950000950170-25-106947
10-Q2025-05-13fiscal Q1 202532670000950170-25-069827
10-K2025-03-25fiscal FY 202434690000950170-25-044099
10-Q2024-11-12fiscal Q3 2024331000000950170-24-124668
10-Q2024-08-12fiscal Q2 202432950000950170-24-095102
10-Q2024-05-13fiscal Q1 202432680000950170-24-058244
10-K2024-04-01fiscal FY 202334690000950170-24-039306
10-Q2023-11-13fiscal Q3 202329920001437749-23-031424
10-Q2023-08-14fiscal Q2 202327820001437749-23-023426
10-Q2023-05-15fiscal Q1 202328600001437749-23-014366
10-K2023-03-22fiscal FY 202230590001437749-23-007531
10-Q2022-11-07fiscal Q3 2022321000001437749-22-026178
10-Q2022-08-08fiscal Q2 202230900001437749-22-019359
10-Q2022-05-09fiscal Q1 202230640001437749-22-011508
10-K2022-02-28fiscal FY 202137750001437749-22-004614
10-Q2021-11-15fiscal Q3 202131940001437749-21-026640
10-Q2021-08-13fiscal Q2 202130880001437749-21-019810
10-Q2021-05-14fiscal Q1 202127570001437749-21-012213
10-K2021-03-31fiscal FY 202036730001437749-21-007756
10-Q2020-11-13fiscal Q3 202029870001437749-20-023747
10-Q2020-08-13fiscal Q2 202029830001437749-20-017738
10-Q2020-05-13fiscal Q1 202027560001437749-20-010514
10-K2020-03-26fiscal FY 201937720001437749-20-006155
10-Q2019-11-13fiscal Q3 201930850001437749-19-022613
10-Q2019-08-13fiscal Q2 201930820001437749-19-016448
10-Q2019-05-13fiscal Q1 201931600001437749-19-009666
10-K2019-03-28fiscal FY 201834680001437749-19-005927
10-Q2018-11-14fiscal Q3 201825670001437749-18-020638
10-Q/A2018-11-13fiscal Q2 201827700001615774-18-012549
10-Q2018-08-13fiscal Q2 201827700001615774-18-007923
10-Q2018-05-14fiscal Q1 201825530001615774-18-003668
10-K2018-03-08fiscal FY 201730600001615774-18-001693
10-Q2017-11-13fiscal Q3 201730750001615774-17-006519
10-Q2017-08-14fiscal Q2 201728690001615774-17-004407
10-Q2017-05-11fiscal Q1 201726500001615774-17-002259
10-Q/A2017-03-21fiscal Q1 201627540001615774-17-001158
10-Q/A2017-03-21fiscal Q2 201629690001615774-17-001155
10-Q/A2017-03-21fiscal Q3 201628700001615774-17-001154
10-K/A2017-03-21fiscal FY 201631610001615774-17-001151
10-K2017-03-16fiscal FY 201631610001615774-17-001088
10-Q2016-11-14fiscal Q3 201630780001144204-16-134190
10-Q2016-08-12fiscal Q2 201633880001144204-16-118486
10-Q2016-05-05fiscal Q1 201631640001144204-16-099233
10-K2016-03-30fiscal FY 201536740001144204-16-091380
10-Q2015-11-12fiscal Q3 201534880001144204-15-064686
10-Q2015-08-06fiscal Q2 201534880001144204-15-046909
10-Q2015-05-13fiscal Q1 201534700001144204-15-030135
10-K2015-03-30fiscal FY 201435720001144204-15-019344
10-Q2014-11-12fiscal Q3 201431860001144204-14-067164
10-Q2014-08-12fiscal Q2 201431860001144204-14-048899
10-Q2014-05-14fiscal Q1 201432820001144204-14-030427
10-K2014-03-27fiscal FY 201332890001144204-14-018247
10-Q2013-11-12fiscal Q3 2013341080001144204-13-060511
10-Q2013-08-14fiscal Q2 2013351100001144204-13-045866
10-Q2013-05-15fiscal Q1 201334890001144204-13-029094
10-K2013-03-28fiscal FY 201233920001144204-13-018024
10-Q/A2013-01-22fiscal Q3 2012331020001144204-13-003214

Inspect the source

Entity
ATOSSA THERAPEUTICS, INC. / CIK 0001488039
Captured
2026-09-20T09:09:43.864Z
SEC response SHA-256
1a9a7394baaf8eaa5fbb9f56ff3e675865210f784ada942417e365f62ac259f6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001488039.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))